How to Buy Seres Therapeutics Stock
Seres Therapeutics Inc
Seres Therapeutics, Inc. , a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease.
Seres Therapeutics stock last closed at $9.00, down 3.54% from the previous day, and has decreased 40.41% in one year. It has underperformed other stocks in the Biotechnology industry by 0.01 percentage points. Seres Therapeutics stock is currently +37.83% from its 52-week low of $6.53, and -69.98% from its 52-week high of $29.98.
At the moment, there are 9.59M shares of MCRB outstanding. The market value of MCRB is $86.28M. In the past 24 hours, 34,300 MCRB shares were traded.
How to Buy Seres Therapeutics Stock
Wondering how to invest in Seres Therapeutics stock? Here's how.
- Choose where to buy Seres Therapeutics stock: You need to choose an online brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you decide where to buy Seres Therapeutics stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Fund your investment account: Pick your method of payment and add your information.
- Research Seres Therapeutics stock: The Seres Therapeutics ticker symbol is MCRB. Is Seres Therapeutics stock a good investment? Should you buy shares of MCRB? How do MCRB's underlying business fundamentals look? Do top analysts think Seres Therapeutics is a good buy? Why has MCRB's stock price moved recently? (Hint: Our stock research tools can help you decide if MCRB is a good stock to buy).
- Execute your MCRB trade: Decide if you will purchase MCRB shares at the current market price or use a limit order to purchase MCRB stock at a given price.
- Get the latest scoop on your MCRB position: Create a watchlist to watch your position in Seres Therapeutics stock.
Step 1: Choose where to buy Seres Therapeutics stock
You need a brokerage account to access the NASDAQ market and buy MCRB shares.
Our preferred brokerage: eToro
Based on our research, eToro is the best online stock brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world financial markets: From Technology to Utilities, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal details so you can buy MCRB today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to create a new brokerage account.
- Send your details by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you have finished signing up on stock market app, you can securely and quickly fund your account:
Check out the video below if you need help depositing funds into your brokerage account.
Step 4: Research Seres Therapeutics stock
After you have identified the best place to buy Seres Therapeutics stock, it's important to evaluate their stock before you buy, so you actually wrap your head around the risk and upside.
Seres Therapeutics quick stats
MCRB Due Diligence Checks
WallStreetZen was created to help everyday investors do more accurate fundamental analysis.
You can see all of the due diligence checks on MCRB's stock page.
Is MCRB stock overvalued?
You can use many financial metrics, analyses, models, and charts to gauge MCRB's true value.
Using relative valuations measures:
- MCRB may be undervalued based on its P/E ratio of 14.06x, relative to Biotechnology industry P/E ratio of 27.96x
- MCRB may be undervalued based on its P/B ratio of 1.95x, relative to Biotechnology industry P/B ratio of 4.52x
You can access more valuation research on MCRB's stock here.
MCRB Financial Health
Passed Health Checks:
- MCRB earnings of $5.70M is not enough to cover its interest payments.
- There are more short-term assets than short-term liabilities on the MCRB balance sheet.
Failed Health Checks:
- There are more long-term liabilities than short-term assets on the MCRB balance sheet.
- MCRB's operating cash flow of $1.12M allows it to safely service it's debt of $82.97M.
- Total MCRB debt is higher than 5 years ago, relative to shareholder equity.
- MCRB has a relatively high debt to equity ratio of 2.13.
Do Wall Street analysts think it's a good time to buy Seres Therapeutics stock
Out of 1 sell side analysts who research MCRB, the consensus analyst rating on Seres Therapeutics is a Strong Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are saying on the Seres Therapeutics stock forecast page.
MCRB Trading Indicators
How are MCRB Revenues/Earnings doing?
Last year, MCRB revenue was $789.00k. In the last five year, MCRB's revenue has increased by -52.67% per year. This was slower than the Biotechnology industry average of 29.01%.
Dig into MCRB's earnings and revenue performance here.
What are MCRB insiders up to?
In the last year, insiders at MCRB have sold more shares than they have bought.
Thomas Desrosier, Chief Legal Officer EVP Co-Chief Executive Officer and Co-President of MCRB, was the latest MCRB insider to sell. They sold $660.66 worth of MCRB stock on Feb 15, 2026.
Get more info about who owns MCRB shares here.
Can I get consistent income from MCRB stock?
No, Seres Therapeutics doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Execute your MCRB trade
You have two primary options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are usually the easiest way to buy. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at an exact dollar amount, place a limit order.
Hit the Open button and your broker will place the order.
If you need additional help buying stocks on eToro, watch the how to video below:
Step 6: Get the latest scoop on your MCRB position
Now that you own some shares in MCRB, you'll want to stay up-to-date on your new investment.
Start a watchlist to track the latest developments regarding your MCRB stock.
MCRB Feed
How to Buy Stock in Seres Therapeutics
To reiterate, here are the 6 steps for buying Seres Therapeutics stock:
- Choose where to buy Seres Therapeutics stock
- Open a brokerage account
- Fund your investment account
- Research Seres Therapeutics stock
- Execute your MCRB trade
- Get the latest scoop on your MCRB position
If you are looking for a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you want to track your new investment in Seres Therapeutics, get started below.
Other Stock Buying Guides You May Find Useful
- Where to buy Amazon stock
- How to buy stock in Netflix online
- How to buy a Tesla stock
- How to buy stock in Berkshire Hathaway online
- Where to invest in stocks
- How to buy stocks in Walmart
- How to purchase Disney stock online
- How to purchase GOOGL stock online
- How to purchase Apple stock
- Where to buy Pfizer stock
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.